Detail Information of Post-Translational Modifications

General Information of Drug Transporter (DT)
DT ID	DTD0352 Transporter Info
Gene Name	SLC3A2
Transporter Name	Lymphocyte activation antigen 4F2
Gene ID	6520
UniProt ID	P08195

Post-Translational Modification of This DT
Overview of SLC3A2 Modification Sites with Functional and Structural Information
Sequence	M E L Q P P E A S I A V V S I P R Q L P G S H S E A G V Q G L S A G D D S E L G S H C V A Q T G L E L L A S G D P L P S A S Q N A E M I E T G S D C V T Q A G L Q L L A S S D P P A L A S K N A E V T G T M S Q D T E V D M K E V E L N E L E P E K Q P M N A A S G A A M S L A G A E K N G L V K I K V A E D E A E A A A A A K F T G L S K E E L L K V A G S P G W V R T R W A L L L L F W L G W L G M L A G A V V I I V R A P R C R E L P A Q K W W H T G A L Y R I G D L Q A F Q G H G A G N L A G L K G R L D Y L S S L K V K G L V L G P I H K N Q K D D V A Q T D L L Q I D P N F G S K E D F D S L L Q S A K K K S I R V I L D L T P N Y R G E N S W F S T Q V D T V A T K V K D A L E F W L Q A G V D G F Q V R D I E N L K D A S S F L A E W Q N I T K G F S E D R L L I A G T N S S D L Q Q I L S L L E S N K D L L L T S S Y L S D S G S T G E H T K S L V T Q Y L N A T G N R W C S W S L S Q A R L L T S F L P A Q L L R L Y Q L M L F T L P G T P V F S Y G D E I G L D A A A L P G Q P M E A P V M L W D E S S F P D I P G A V S A N M T V K G Q S E D P G S L L S L F R R L S D Q R S K E R S L L H G D F H A F S A G P G L F S Y I R H W D Q N E R F L V V L N F G D V G L S A G L Q A S D L P A S A S L P A K A D L L L S T Q P G R E E G S P L E L E R L K L E P H E G L L L R F P Y A A
PTM type	X-Acetylation X-Disulfide bond X-Methylation X-N-glycosylation X-Phosphorylation X-S-nitrosylation X-S-palmitoylation X-Succinylation X-Sulfoxidation X-Ubiquitination X: Amino Acid

Acetylation
Glutamicacid	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC3A2			[1] , [2]
Role of PTM	Potential impacts
Modified Residue	Glutamicacid	Modified Location	2
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at SLC3A2 Glutamicacid 2 has the potential to affect its expression or activity.
Lysine	10 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC3A2			[3]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	147
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at SLC3A2 Lysine 147 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC3A2			[4]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	160
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at SLC3A2 Lysine 160 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC3A2			[3] , [4]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	166
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at SLC3A2 Lysine 166 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC3A2			[4]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	217
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at SLC3A2 Lysine 217 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence SLC3A2			[3]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	245
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at SLC3A2 Lysine 245 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence SLC3A2			[4]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	255
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at SLC3A2 Lysine 255 has the potential to affect its expression or activity.
PTM Phenomenon 7	Have the potential to influence SLC3A2			[4]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	266
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at SLC3A2 Lysine 266 has the potential to affect its expression or activity.
PTM Phenomenon 8	Have the potential to influence SLC3A2			[3]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	287
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at SLC3A2 Lysine 287 has the potential to affect its expression or activity.
PTM Phenomenon 9	Have the potential to influence SLC3A2			[4]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	298
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at SLC3A2 Lysine 298 has the potential to affect its expression or activity.
PTM Phenomenon 10	Have the potential to influence SLC3A2			[3]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	615
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at SLC3A2 Lysine 615 has the potential to affect its expression or activity.
Methionine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC3A2			[5]
Role of PTM	Potential impacts
Modified Residue	Methionine	Modified Location	1
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at SLC3A2 Methionine 1 has the potential to affect its expression or activity.
Serine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC3A2			[1] , [2]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	41
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at SLC3A2 Serine 41 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC3A2			[1] , [2]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	103
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at SLC3A2 Serine 103 has the potential to affect its expression or activity.
Disulfide bond
Cystine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC3A2			[6]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	210
Experimental Method	Co-Immunoprecipitation
Detailed Description	Disulfide bond (-SSR) at SLC3A2 Cystine 210 has the potential to affect its expression or activity.
Methylation
Arginine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC3A2			[7]
Role of PTM	Potential impacts
Modified Residue	Arginine	Modified Location	625
Experimental Method	Co-Immunoprecipitation
Detailed Description	Methylation at SLC3A2 Arginine 625 has the potential to affect its expression or activity.
N-glycosylation
Asparagine	6 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC3A2			[8]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	365
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at SLC3A2 Asparagine 365 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC3A2			[8]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	381
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at SLC3A2 Asparagine 381 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC3A2			[9]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	395
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at SLC3A2 Asparagine 395 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC3A2			[8]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	424
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at SLC3A2 Asparagine 424 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence SLC3A2			[9]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	428
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at SLC3A2 Asparagine 428 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence SLC3A2			[8]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	506
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at SLC3A2 Asparagine 506 has the potential to affect its expression or activity.
Phosphorylation
Glutamicacid	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC3A2			[10]
Role of PTM	Potential impacts
Modified Residue	Glutamicacid	Modified Location	2
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC3A2 Glutamicacid 2 has the potential to affect its expression or activity.
Leucine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC3A2			[11]
Role of PTM	Potential impacts
Modified Residue	Leucine	Modified Location	135
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC3A2 Leucine 135 has the potential to affect its expression or activity.
Proline	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC3A2			[10]
Role of PTM	Potential impacts
Modified Residue	Proline	Modified Location	5
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC3A2 Proline 5 has the potential to affect its expression or activity.
Serine	29 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Facilitating heterotypic cell-cell interactions			[12]
Role of PTM	Protein Activity Modulation
Modified Residue	Serine	Modified Location	406
Related Enzyme	Casein kinase 2 (CSNK2A2)
Studied Phenotype	Colon cancer [ICD11: 2B90]
Experimental Material(s)	Human colon carcinoma (Caco2) cells
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC3A2 Serine 406 have been reported to facilitate its heterotypic cell-cell interactions.
PTM Phenomenon 2	Facilitating heterotypic cell-cell interactions			[12]
Role of PTM	Protein Activity Modulation
Modified Residue	Serine	Modified Location	408
Related Enzyme	Casein kinase 2 (CSNK2A2)
Studied Phenotype	Colon cancer [ICD11: 2B90]
Experimental Material(s)	Human colon carcinoma (Caco2) cells
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC3A2 Serine 408 have been reported to facilitate its heterotypic cell-cell interactions.
PTM Phenomenon 3	Facilitating heterotypic cell-cell interactions			[12]
Role of PTM	Protein Activity Modulation
Modified Residue	Serine	Modified Location	410
Related Enzyme	Casein kinase 2 (CSNK2A2)
Studied Phenotype	Colon cancer [ICD11: 2B90]
Experimental Material(s)	Human colon carcinoma (Caco2) cells
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC3A2 Serine 410 have been reported to facilitate its heterotypic cell-cell interactions.
PTM Phenomenon 4	Facilitating heterotypic cell-cell interactions			[12]
Role of PTM	Protein Activity Modulation
Modified Residue	Serine	Modified Location	527
Related Enzyme	Casein kinase 2 (CSNK2A2)
Studied Phenotype	Colon cancer [ICD11: 2B90]
Experimental Material(s)	Human colon carcinoma (Caco2) cells
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC3A2 Serine 527 have been reported to facilitate its heterotypic cell-cell interactions.
PTM Phenomenon 5	Facilitating heterotypic cell-cell interactions			[12]
Role of PTM	Protein Activity Modulation
Modified Residue	Serine	Modified Location	531
Related Enzyme	Casein kinase 2 (CSNK2A2)
Studied Phenotype	Colon cancer [ICD11: 2B90]
Experimental Material(s)	Human colon carcinoma (Caco2) cells
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC3A2 Serine 531 have been reported to facilitate its heterotypic cell-cell interactions.
PTM Phenomenon 6	Have the potential to influence SLC3A2			[1] , [13]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	9
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC3A2 Serine 9 has the potential to affect its expression or activity.
PTM Phenomenon 7	Have the potential to influence SLC3A2			[14] , [15]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	14
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC3A2 Serine 14 has the potential to affect its expression or activity.
PTM Phenomenon 8	Have the potential to influence SLC3A2			[11]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	37
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC3A2 Serine 37 has the potential to affect its expression or activity.
PTM Phenomenon 9	Have the potential to influence SLC3A2			[1] , [2]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	41
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC3A2 Serine 41 has the potential to affect its expression or activity.
PTM Phenomenon 10	Have the potential to influence SLC3A2			[1] , [2]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	72
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC3A2 Serine 72 has the potential to affect its expression or activity.
PTM Phenomenon 11	Have the potential to influence SLC3A2			[16] , [17]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	103
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC3A2 Serine 103 has the potential to affect its expression or activity.
PTM Phenomenon 12	Have the potential to influence SLC3A2			[18] , [19]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	129
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC3A2 Serine 129 has the potential to affect its expression or activity.
PTM Phenomenon 13	Have the potential to influence SLC3A2			[16] , [18]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	134
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC3A2 Serine 134 has the potential to affect its expression or activity.
PTM Phenomenon 14	Have the potential to influence SLC3A2			[20] , [21]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	165
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC3A2 Serine 165 has the potential to affect its expression or activity.
PTM Phenomenon 15	Have the potential to influence SLC3A2			[22] , [23]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	175
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC3A2 Serine 175 has the potential to affect its expression or activity.
PTM Phenomenon 16	Have the potential to influence SLC3A2			[14] , [24]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	252
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC3A2 Serine 252 has the potential to affect its expression or activity.
PTM Phenomenon 17	Have the potential to influence SLC3A2			[24] , [25]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	253
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC3A2 Serine 253 has the potential to affect its expression or activity.
PTM Phenomenon 18	Have the potential to influence SLC3A2			[26] , [27]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	292
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC3A2 Serine 292 has the potential to affect its expression or activity.
PTM Phenomenon 19	Have the potential to influence SLC3A2			[28] , [29]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	296
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC3A2 Serine 296 has the potential to affect its expression or activity.
PTM Phenomenon 20	Have the potential to influence SLC3A2			[30]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	301
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC3A2 Serine 301 has the potential to affect its expression or activity.
PTM Phenomenon 21	Have the potential to influence SLC3A2			[27]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	317
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC3A2 Serine 317 has the potential to affect its expression or activity.
PTM Phenomenon 22	Have the potential to influence SLC3A2			[27]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	320
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC3A2 Serine 320 has the potential to affect its expression or activity.
PTM Phenomenon 23	Have the potential to influence SLC3A2			[26] , [27]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	513
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC3A2 Serine 513 has the potential to affect its expression or activity.
PTM Phenomenon 24	Have the potential to influence SLC3A2			[27]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	518
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC3A2 Serine 518 has the potential to affect its expression or activity.
PTM Phenomenon 25	Have the potential to influence SLC3A2			[14] , [27]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	521
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC3A2 Serine 521 has the potential to affect its expression or activity.
PTM Phenomenon 26	Have the potential to influence SLC3A2			[1]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	545
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC3A2 Serine 545 has the potential to affect its expression or activity.
PTM Phenomenon 27	Have the potential to influence SLC3A2			[14]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	552
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC3A2 Serine 552 has the potential to affect its expression or activity.
PTM Phenomenon 28	Have the potential to influence SLC3A2			[27]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	598
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC3A2 Serine 598 has the potential to affect its expression or activity.
PTM Phenomenon 29	Have the potential to influence SLC3A2			[31] , [32]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	607
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC3A2 Serine 607 has the potential to affect its expression or activity.
Threonine	7 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC3A2			[33]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	70
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC3A2 Threonine 70 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC3A2			[33]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	76
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC3A2 Threonine 76 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC3A2			[23] , [34]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	99
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC3A2 Threonine 99 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC3A2			[34] , [35]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	101
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC3A2 Threonine 101 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence SLC3A2			[22] , [36]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	106
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC3A2 Threonine 106 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence SLC3A2			[19] , [37]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	162
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC3A2 Threonine 162 has the potential to affect its expression or activity.
PTM Phenomenon 7	Have the potential to influence SLC3A2			[27]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	321
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC3A2 Threonine 321 has the potential to affect its expression or activity.
Tyrosine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC3A2			[24] , [30]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	250
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC3A2 Tyrosine 250 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC3A2			[30]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	312
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC3A2 Tyrosine 312 has the potential to affect its expression or activity.
S-nitrosylation
Cystine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC3A2			[38]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	431
Experimental Method	Co-Immunoprecipitation
Detailed Description	S-nitrosylation (-SNO) at SLC3A2 Cystine 431 has the potential to affect its expression or activity.
S-palmitoylation
Cystine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC3A2			[39]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	431
Experimental Method	Co-Immunoprecipitation
Detailed Description	S-palmitoylation at SLC3A2 Cystine 431 has the potential to affect its expression or activity.
Succinylation
Lysine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC3A2			[40]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	298
Experimental Method	Co-Immunoprecipitation
Detailed Description	Succinylation at SLC3A2 Lysine 298 has the potential to affect its expression or activity.
Sulfoxidation
Methionine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC3A2			[41]
Role of PTM	Potential impacts
Modified Residue	Methionine	Modified Location	125
Experimental Method	Co-Immunoprecipitation
Detailed Description	Sulfoxidation at SLC3A2 Methionine 125 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC3A2			[41]
Role of PTM	Potential impacts
Modified Residue	Methionine	Modified Location	133
Experimental Method	Co-Immunoprecipitation
Detailed Description	Sulfoxidation at SLC3A2 Methionine 133 has the potential to affect its expression or activity.
Ubiquitination
Lysine	16 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC3A2			[42]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	111
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC3A2 Lysine 111 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC3A2			[43]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	122
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC3A2 Lysine 122 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC3A2			[42]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	140
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC3A2 Lysine 140 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC3A2			[42]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	145
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC3A2 Lysine 145 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence SLC3A2			[44]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	147
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC3A2 Lysine 147 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence SLC3A2			[44]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	160
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC3A2 Lysine 160 has the potential to affect its expression or activity.
PTM Phenomenon 7	Have the potential to influence SLC3A2			[44]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	166
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC3A2 Lysine 166 has the potential to affect its expression or activity.
PTM Phenomenon 8	Have the potential to influence SLC3A2			[44]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	171
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC3A2 Lysine 171 has the potential to affect its expression or activity.
PTM Phenomenon 9	Have the potential to influence SLC3A2			[42]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	245
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC3A2 Lysine 245 has the potential to affect its expression or activity.
PTM Phenomenon 10	Have the potential to influence SLC3A2			[42]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	269
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC3A2 Lysine 269 has the potential to affect its expression or activity.
PTM Phenomenon 11	Have the potential to influence SLC3A2			[42]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	287
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC3A2 Lysine 287 has the potential to affect its expression or activity.
PTM Phenomenon 12	Have the potential to influence SLC3A2			[42]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	329
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC3A2 Lysine 329 has the potential to affect its expression or activity.
PTM Phenomenon 13	Have the potential to influence SLC3A2			[42]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	354
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC3A2 Lysine 354 has the potential to affect its expression or activity.
PTM Phenomenon 14	Have the potential to influence SLC3A2			[42]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	368
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC3A2 Lysine 368 has the potential to affect its expression or activity.
PTM Phenomenon 15	Have the potential to influence SLC3A2			[42]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	416
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC3A2 Lysine 416 has the potential to affect its expression or activity.
PTM Phenomenon 16	Have the potential to influence SLC3A2			[45]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	615
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC3A2 Lysine 615 has the potential to affect its expression or activity.

References
1	Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis. Sci Signal. 2010 Jan 12;3(104):ra3.
2	Quantitative analysis of the human spindle phosphoproteome at distinct mitotic stages. J Proteome Res. 2009 Oct;8(10):4553-63.
3	Quantitative Proteomic Atlas of Ubiquitination and Acetylation in the DNA Damage Response. Mol Cell. 2015 Sep 3;59(5):867-81.
4	Lysine Acetylation and Succinylation in HeLa Cells and their Essential Roles in Response to UV-induced Stress. Sci Rep. 2016 Jul 25;6:30212.
5	N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB. Proc Natl Acad Sci U S A. 2012 Jul 31;109(31):12449-54.
6	iCysMod: an integrative database for protein cysteine modifications in eukaryotes. Brief Bioinform. 2021 Sep 2;22(5):bbaa400. (ID: P08195)
7	dbPTM in 2022: an updated database for exploring regulatory networks and functional associations of protein post-translational modifications. Nucleic Acids Res. 2022 Jan 7;50(D1):D471-D479. (ID: 4F2_HUMAN)
8	Structure of the human LAT1-4F2hc heteromeric amino acid transporter complex. Nature. 2019 Apr;568(7750):127-130.
9	Mass-spectrometric identification and relative quantification of N-linked cell surface glycoproteins. Nat Biotechnol. 2009 Apr;27(4):378-86.
10	Global, in vivo, and site-specific phosphorylation dynamics in signaling networks. Cell. 2006 Nov 3;127(3):635-48.
11	Proteogenomics connects somatic mutations to signalling in breast cancer. Nature. 2016 Jun 2;534(7605):55-62.
12	Ecto-phosphorylation of CD98 regulates cell-cell interactions. PLoS One. 2008;3(12):e3895.
13	Systematic functional prioritization of protein posttranslational modifications. Cell. 2012 Jul 20;150(2):413-25.
14	Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics. 2014 Jul;13(7):1690-704.
15	Phosphoproteome Characterization of Human Colorectal Cancer SW620 Cell-Derived Exosomes and New Phosphosite Discovery for C-HPP. J Proteome Res. 2016 Nov 4;15(11):4060-4072.
16	UniProt: a worldwide hub of protein knowledge. Nucleic Acids Res. 2019 Jan 8;47(D1):D506-D515.
17	An orthogonal proteomic survey uncovers novel Zika virus host factors. Nature. 2018 Sep;561(7722):253-257.
18	Robust, Reproducible, and Economical Phosphopeptide Enrichment Using Calcium Titanate. J Proteome Res. 2019 Mar 1;18(3):1411-1417.
19	Phosphoproteomic screening identifies physiological substrates of the CDKL5 kinase. EMBO J. 2018 Dec 14;37(24):e99559.
20	Capillary Zone Electrophoresis-Tandem Mass Spectrometry for Large-Scale Phosphoproteomics with the Production of over 11,000 Phosphopeptides from the Colon Carcinoma HCT116 Cell Line. Anal Chem. 2019 Feb 5;91(3):2201-2208.
21	Quantitative Phosphoproteome Analysis of Clostridioides difficile Toxin B Treated Human Epithelial Cells. Front Microbiol. 2018 Dec 17;9:3083.
22	Offline pentafluorophenyl (PFP)-RP prefractionation as an alternative to high-pH RP for comprehensive LC-MS/MS proteomics and phosphoproteomics. Anal Bioanal Chem. 2017 Jul;409(19):4615-4625.
23	Isoelectric point-based fractionation by HiRIEF coupled to LC-MS allows for in-depth quantitative analysis of the phosphoproteome. Sci Rep. 2017 Jul 3;7(1):4513.
24	Deep Phosphotyrosine Proteomics by Optimization of Phosphotyrosine Enrichment and MS/MS Parameters. J Proteome Res. 2017 Feb 3;16(2):1077-1086.
25	Improving depth in phosphoproteomics by using a strong cation exchange-weak anion exchange-reversed phase multidimensional separation approach. Anal Chem. 2011 Sep 15;83(18):7137-43.
26	Tip-Based Fractionation of Batch-Enriched Phosphopeptides Facilitates Easy and Robust Phosphoproteome Analysis. J Proteome Res. 2018 Jan 5;17(1):46-54.
27	Quantitative phosphoproteomics identifies substrates and functional modules of Aurora and Polo-like kinase activities in mitotic cells. Sci Signal. 2011 Jun 28;4(179):rs5.
28	Protein kinase C-alpha interaction with F0F1-ATPase promotes F0F1-ATPase activity and reduces energy deficits in injured renal cells. J Biol Chem. 2015 Mar 13;290(11):7054-66.
29	Ultradeep human phosphoproteome reveals a distinct regulatory nature of Tyr and Ser/Thr-based signaling. Cell Rep. 2014 Sep 11;8(5):1583-94.
30	Motif-specific sampling of phosphoproteomes. J Proteome Res. 2008 May;7(5):2140-50.
31	Identification of extracellular signal-regulated kinase 1 (ERK1) direct substrates using stable isotope labeled kinase assay-linked phosphoproteomics. Mol Cell Proteomics. 2014 Nov;13(11):3199-210.
32	Quantitative global phosphoproteomics of human umbilical vein endothelial cells after activation of the Rap signaling pathway. Mol Biosyst. 2013 Apr 5;9(4):732-49.
33	Improve the coverage for the analysis of phosphoproteome of HeLa cells by a tandem digestion approach. J Proteome Res. 2012 May 4;11(5):2828-37.
34	Identification of Candidate Cyclin-dependent kinase 1 (Cdk1) Substrates in Mitosis by Quantitative Phosphoproteomics. Mol Cell Proteomics. 2016 Jul;15(7):2448-61.
35	System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation. Sci Signal. 2011 Mar 15;4(164):rs3.
36	CEP128 Localizes to the Subdistal Appendages of the Mother Centriole and Regulates TGF-beta/BMP Signaling at the Primary Cilium. Cell Rep. 2018 Mar 6;22(10):2584-2592.
37	Chronic exposure to cigarette smoke leads to activation of p21 (RAC1)-activated kinase 6 (PAK6) in non-small cell lung cancer cells. Oncotarget. 2016 Sep 20;7(38):61229-61245.
38	Proteome-wide detection of S-nitrosylation targets and motifs using bioorthogonal cleavable-linker-based enrichment and switch technique. Nat Commun. 2019 May 16;10(1):2195.
39	Selective Enrichment and Direct Analysis of Protein S-Palmitoylation Sites. J Proteome Res. 2018 May 4;17(5):1907-1922.
40	Lysine succinylation is a frequently occurring modification in prokaryotes and eukaryotes and extensively overlaps with acetylation. Cell Rep. 2013 Aug 29;4(4):842-51.
41	Oxidation of protein-bound methionine in Photofrin-photodynamic therapy-treated human tumor cells explored by methionine-containing peptide enrichment and quantitative proteomics approach. Sci Rep. 2017 May 2;7(1):1370.
42	Systematic and quantitative assessment of the ubiquitin-modified proteome. Mol Cell. 2011 Oct 21;44(2):325-40.
43	A data set of human endogenous protein ubiquitination sites. Mol Cell Proteomics. 2011 May;10(5):M110.002089.
44	A proteome-wide, quantitative survey of in vivo ubiquitylation sites reveals widespread regulatory roles. Mol Cell Proteomics. 2011 Oct;10(10):M111.013284.
45	New findings on essential amino acids. Cesk Fysiol. 1990;39(1):13-25.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.

Detail Information of Post-Translational Modifications

Visitor Map

Correspondence